A Multi-Center Trial to Study Acute Liver Failure in Adults
NCT00518440 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3488
Last updated 2022-01-28
Summary
The purpose of this study is to collect clinical and epidemiological data as well as serum, plasma, urine, tissue and DNA samples on individuals who have acute liver failure and on individuals who have acute liver injury, a less severe group of patients who have coagulopathy but do not reach the threshold of encephalopathy.
Conditions
- Acute Liver Failure
- Fulminant Hepatic Failure
- Acute Liver Injury
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
William Lee
lead OTHER
Principal Investigators
-
William M Lee, MD · University of Southwestern Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-01-31
- Primary Completion
- 2019-09-18
- Completion
- 2019-09-18
Countries
- United States
- Canada
Study Locations
More Related Trials
-
A Study of the Effect of Plasmaexchange in Patients With Acute Liver Failure
NCT00950508 ·Status: COMPLETED ·Phase: NA
-
Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen
NCT00004467 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Safety and Efficacy of Preemptive Administration of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema
NCT04991259 ·Status: UNKNOWN ·Phase: NA
-
Unknown Cause of Acute Liver Failure
NCT02041637 ·Status: COMPLETED
-
Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study
NCT03056612 ·Status: COMPLETED
-
High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure
NCT02718079 ·Status: COMPLETED ·Phase: NA
-
Patients' Outcome With Severe or Fulminant Hepatic Insufficiency, Hospitalized in the Public Hospitals of Paris
NCT04658407 ·Status: UNKNOWN
-
Efficacy of High Dose Albumin Therapy in Improving Liver Transplant-free Survival in Patients With Acute Decompensation of Cirrhosis
NCT05956197 ·Status: UNKNOWN
-
Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.
NCT04311489 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of Coagulation Profile and Haematopoietic Responses in Patients With Acute-on-chronic Liver Failure During Systemic Inflammatory Response (SIRS) and Sepsis
NCT02307409 ·Status: COMPLETED
-
Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy
NCT05124041 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis
NCT04806581 ·Status: UNKNOWN ·Phase: PHASE1
-
Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease
NCT02366845 ·Status: COMPLETED ·Phase: PHASE4
-
Albumin Infusion in Inpatients With Decompensated Cirrhosis
NCT05719051 ·Status: UNKNOWN
-
To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase
NCT02788240 ·Status: TERMINATED ·Phase: NA
-
To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.
NCT02465619 ·Status: WITHDRAWN
-
Prognosis of Patients With Acute-on-chronic Liver Failure
NCT05393453 ·Status: UNKNOWN
-
A Multi-Center Group to Study Acute Liver Failure in Children
NCT00986648 ·Status: COMPLETED
-
Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%
NCT03702920 ·Status: TERMINATED ·Phase: PHASE3
-
Prognostic Significance of Acute Change in Liver and Splenic Stiffness in Patients of Acute on Chronic Liver Failure
NCT06069284 ·Status: UNKNOWN
-
Evaluation of Mechanisms Responsible for Coma in Patients Affected by Fulminant, Acute and Chronic Hepatic Failure
NCT01582087 ·Status: TERMINATED
-
Haemostatic Imbalance in Patients With Chronic Liver Disease
NCT03589430 ·Status: UNKNOWN
-
Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.
NCT04679571 ·Status: UNKNOWN ·Phase: NA
-
To Compare Relaxed Rotational Thromboelastometry Cut-offs With Standard Cut-offs for Guiding Blood Product Use Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure Patients
NCT05672589 ·Status: UNKNOWN ·Phase: NA
-
To Determine the Predictors of Reversibility for Acute-on-Chronic Liver Failure at 6-months.
NCT06387160 ·Status: NOT_YET_RECRUITING